Womens Laxative
- Product NDC
- 21130-552
- 11-digit product format
- 211300552
- Labeler code
- 21130
- Product ID
- 21130-552_5cb1845c-ab22-a1ce-e063-6294a90acd1e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bisacodyl
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BETTER LIVING BRANDS LLC.
- Application
- 505G(a)(3)
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-10-21
- Substance
- BISACODYL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Womens Laxative
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BISACODYL | 5 mg/1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 21130-552-30 | 21130055230 | 2 BLISTER PACK in 1 CARTON (21130-552-30) / 15 TABLET in 1 BLISTER PACK | 2 blister pack | 2026-10-21 | No | No | Current |